Health Canada has issued a strong warning against the purchase and use of unauthorized or counterfeit GLP-1 drugs, including the widely recognized semaglutide, an active ingredient...
Novo Nordisk Canada is set to introduce lower-priced versions of its widely used medications, Ozempic and Wegovy, in a strategic move to compete with upcoming generics....
URGENT UPDATE: Novo Nordisk Canada has just announced plans to introduce lower-priced versions of its popular diabetes and weight-loss drugs, Ozempic and Wegovy, as competition from...
Health Canada is currently reviewing nine submissions for generic versions of widely used weight loss medications, a move that could significantly reduce prices for Canadians this...
UPDATE: The U.S. Food and Drug Administration (FDA) has just approved Novo Nordisk’s groundbreaking weight-loss pill, Wegovy, marking a significant milestone in the fight against obesity....
The European Medicines Agency’s committee has recommended the extension of Eli Lilly’s diabetes medication, Mounjaro, for use in children and adolescents aged 10 years and older....
Negotiations aimed at securing public health coverage for the weight-loss drug Wegovy in Canada have stalled. Danish pharmaceutical company Novo Nordisk, the manufacturer of Wegovy, declined...
Novo Nordisk plans to launch an oral version of its highly successful weight loss medication, Wegovy (semaglutide), pending approval from the United States Food and Drug...
Africa’s largest pharmaceutical company, Aspen Pharmacare Holdings Ltd., is set to produce affordable generic versions of popular obesity drugs, including Ozempic, Wegovy, and Mounjaro, starting in...
Canadians may soon have access to more affordable versions of medications like Ozempic and Wegovy, with generic options potentially hitting the market as early as January...
